Moderna, Inc. vs Oatly Group AB - ADR — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Oatly Group AB - ADR trades at $9.85 (market cap $308.50M). The key difference: Moderna, Inc. is far larger — about 76.5× Oatly Group AB - ADR's market cap, and Moderna, Inc. is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals.
| MRNA | OTLY | |
|---|---|---|
Market Cap | $23.60B | $308.50M |
Sector | Health | Consumer Staples |
52-Week High | $81.80 | $18.54 |
52-Week Low | $22.36 | $8.03 |
Enterprise Value | $19.70B | $806.12M |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →